Houdini Bio
PrivateLast Round
Pre Seed
Jun 19, 2026
Est. Valuation
$14M
Total Funding Raised
$2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Houdini Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Pre Seed round in June 2026.
Houdini Bio is a biotechnology company that provides a DNA sequence design infrastructure platform, using machine learning to overcome biological barriers in genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Houdini Bio Comparables
Compare Houdini Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Form Bio | 74% | |
| Asimov | 64% | |
| Ternary Therapeutics | 54% |
For institutional investors. Book with your work email.
Houdini Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Houdini Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Pre Seed |
| Deep Science Ventures | Pre Seed |
| Cambridge Enterprise Ventures | Pre Seed |
| Science Creates Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 63% MoM.
- Jun 19, 2026
$2M round led by SCVC
For institutional investors. Book with your work email.
Houdini Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Houdini Bio's valuation, stock price, and market status.
Is Houdini Bio a public or private company?
Houdini Bio is a private company.
What is the current stock price of Houdini Bio?
Houdini Bio is a private company, so its shares have no public market price. Caplight tracks Houdini Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Houdini Bio worth (valuation)?
Houdini Bio's valuation is estimated at $14.0M based on funding round data.
Can I buy Houdini Bio stock?
Houdini Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Houdini Bio's last funding round?
Houdini Bio's most recent funding round was Pre Seed on June 19, 2026.
Who are the main investors in Houdini Bio?
Key investors in Houdini Bio include SCVC, Science Creates Ventures.
Will Houdini Bio IPO soon?
No public IPO plans have been announced for Houdini Bio.
How can I track Houdini Bio secondary market activity?
Caplight tracks bids, offers, and trades in Houdini Bio's shares on secondary markets.